NT–probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non–ST-elevation acute coronary syndromes José Luis Navarro Estrada, MD, FACC, MSc, Fernando Rubinstein, MD, MSc, Maria Cecilia Bahit, MD, Florencia Rolandi, MD, Diego Perez de Arenaza, MD, Jose M. Gabay, MD, Jose Alvarez, MD, Ricardo Sarmiento, MD, Carlos Rojas Matas, MD, Carlos Sztejfman, MD, Alejandro Tettamanzi, MD, Raul de Miguel, Biochem, Luis Guzman, MD, FACC American Heart Journal Volume 151, Issue 5, Pages 1093.e1-1093.e7 (May 2006) DOI: 10.1016/j.ahj.2005.12.020 Copyright © 2006 Mosby, Inc. Terms and Conditions
Figure 1 Complex coronary lesion stratified by NT-proBNP levels. American Heart Journal 2006 151, 1093.e1-1093.e7DOI: (10.1016/j.ahj.2005.12.020) Copyright © 2006 Mosby, Inc. Terms and Conditions
Figure 2 Left ventricular function and NT-proBNP levels. Results are expressed as median and interquartile range. American Heart Journal 2006 151, 1093.e1-1093.e7DOI: (10.1016/j.ahj.2005.12.020) Copyright © 2006 Mosby, Inc. Terms and Conditions
Figure 3 Coronary artery disease extension and NT-proBNP levels. Results are expressed as median and interquartile range. American Heart Journal 2006 151, 1093.e1-1093.e7DOI: (10.1016/j.ahj.2005.12.020) Copyright © 2006 Mosby, Inc. Terms and Conditions
Figure 4 Supramedian NT-proBNP levels according to LV function and extension of CAD. American Heart Journal 2006 151, 1093.e1-1093.e7DOI: (10.1016/j.ahj.2005.12.020) Copyright © 2006 Mosby, Inc. Terms and Conditions
Figure 5 Stepwise logistic regression model for the prediction of complex coronary lesion. NT-proBNP 278, Supramedian NT-proBNP level. American Heart Journal 2006 151, 1093.e1-1093.e7DOI: (10.1016/j.ahj.2005.12.020) Copyright © 2006 Mosby, Inc. Terms and Conditions